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Background
MSM constitute one of the populations most affected by
HIV and other STIs in Argentina. Previous prevalence
studies were based on convenience samples. RDS, a meth-
odology designed to access hidden populations, is being
used for the first time in Argentina to recruit MSM.
Methods
RDS recruitment started in November 2007 with 16 first
generation participants (seeds) who were selected for their
potential to tap in MSM networks. Recruitment is ongo-
ing. Men must be 18 years of age or older, be residents of
Buenos Aires, self-report having sex with men at least 10
times in their lives and at least once in the past six months.
They must have a coupon indicating they have been
referred by a study participant. Specimens are being col-
lected for HIV and STI diagnosis. All data are weighted
using the RDS Analysis Tool (RDSAT).
Results
To date, 333 MSM were recruited through RDS showing a
prevalence of 11.3, 16.6, 7.9, 17.6, 4.0 and 88.3% for HIV,
HBV, HCV, T. pallidum, Chlamydia and HPV, respectively.
Chlamydia and HPV diagnoses were only performed in 73
and 79 participants, respectively. Among HPV positive
individuals, 47.8% had almost one of these high risk types
(16, 58, 33, 45, 18 and 31) and 32% had multiple infec-
tions with 2 or more types.
Conclusion
Compared with previous studies, these results show simi-
lar HIV, HBV and T. pallidum prevalences but higher HCV
prevalence. For the first time, an elevated prevalence of
HPV was detected on MSM, with high frequency of types
associated with ano-genital cancer. Preliminary analyses
of socio demographic data show that RDS helps recruit a
diversity of MSM, particularly of lower socio-economic
level usually missed with other recruitment methods. The
high prevalence of coinfections in this population should
be taken into account if MSM are part of vaccine trials
given that STI may increase HIV sexual transmission.
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